PRAEVENTIX

Praeventix is an early-stage biotech company committed to the discovery, research and early clinical development of novel serotonergic therapeutics with potential applications in dermatologic, autoimmune and neurodegenerative diseases... Praeventix was founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University... Praeventix is focused on the development of novel 5-HT7 receptor antagonists as potential treatments for chronic pruritus, IBD and cocaine use disorder

Also known as: Praeventix Inc.

Primary location: Exton United States